all AI news
MolCRAFT: Structure-Based Drug Design in Continuous Parameter Space
April 19, 2024, 4:42 a.m. | Yanru Qu, Keyue Qiu, Yuxuan Song, Jingjing Gong, Jiawei Han, Mingyue Zheng, Hao Zhou, Wei-Ying Ma
cs.LG updates on arXiv.org arxiv.org
Abstract: Generative models for structure-based drug design (SBDD) have shown promising results in recent years. Existing works mainly focus on how to generate molecules with higher binding affinity, ignoring the feasibility prerequisites for generated 3D poses and resulting in false positives. We conduct thorough studies on key factors of ill-conformational problems when applying autoregressive methods and diffusion to SBDD, including mode collapse and hybrid continuous-discrete space. In this paper, we introduce \ours, the first SBDD model …
arxiv continuous cs.lg design drug design q-bio.bm space type
More from arxiv.org / cs.LG updates on arXiv.org
Jobs in AI, ML, Big Data
Software Engineer for AI Training Data (School Specific)
@ G2i Inc | Remote
Software Engineer for AI Training Data (Python)
@ G2i Inc | Remote
Software Engineer for AI Training Data (Tier 2)
@ G2i Inc | Remote
Data Engineer
@ Lemon.io | Remote: Europe, LATAM, Canada, UK, Asia, Oceania
Artificial Intelligence – Bioinformatic Expert
@ University of Texas Medical Branch | Galveston, TX
Lead Developer (AI)
@ Cere Network | San Francisco, US